@DrLKVaughan@TheSnoozeDoctor All senior managers should spend time on the ‘shop floor’. It’s policy at large organisations such as Tesco, to ensure senior staff understand the job they are managing
@AffinityWater there looks be two burst water mains on Totteridge Lane London N20, junction will Hill Crescent. Not great given the drought! But nice view of eclipse from the top of the hill
@DrLKVaughan This one is particularly ridiculous and will slow down managing any complaints thereby reducing patient satisfaction with that process or learning from complaints.
ERJ Open Research: Young adults with severe asthma experience disproportionately poor outcomes despite specialist care, highlighting the need for age-appropriate personalised management https://t.co/ACGI5297fz
#newpublication Alert ‼️
EGPA, benralizumab reduced airway autoimmune responses (spANCA and IL-17A) and eosinophilic inflammation, while mepolizumab was linked to persistent or increased autoimmune activity https://t.co/GiAp32BTz0 check out the mechanistic substudy of #Mandara Trial #MukherjeeLab
Shout out to PhD student Nadia Suray Tan for the crucial work @machealthsci@ResearchStJoes@ERSpublications
New respiratory education account
Sharing Respiratory SCE-style questions, exam tips, and regular updates on UK courses, key papers, podcasts and exam news.
Follow along and learn together.
#MedTwitter#Mededucation@LancetRespirMed@BTOGORG
@BTSrespiratory
ERJOR: Severe asthma biologics are effective in a broad range of patients, including those not meeting the inclusion/exclusion criteria for phase 3 RCTs, although noninferiority could not be shown for those RCT-ineligible by poor medication adherence https://t.co/jAscfptOze
@ImogenSkene And to provide patient-friendly education on why we might advise changes to inhaled therapy. @NHSBartsHealth@NELHCP https://t.co/WnvJY0cQnB
Great to see our new paper out showing the cardiovascular dangers from high SABA blue reliever use. And our recent research on implementing SABA-free management. @QMULBartsTheLon@opri_sg https://t.co/t0HLn3HWen
Important to understand the health beliefs of patients towards changes to their asthma medication, including in emergency settings @ImogenSkene https://t.co/9CfrXlWKWZ https://t.co/WZlhiEPhc6
Is an Emergency Department presentation at opportunity to tackle SABA overuse and improve asthma control?
Our new paper explores patient beliefs, and attitudes to inhaler changes @DoctorPfeff
https://t.co/ONZlCRlzCI
#Asthma#EmergencyMedicine
We've developed a short video for people with asthma who may be offered a new type of inhaler therapy called MART or AIR.
🎥 Watch the video here: https://t.co/tC7WpFph9V
✅ Right medication
✅ Right way
✅ Right support
#asthma@DoctorPfeff
@ImogenSkene Can we do better than just prescribing SABA and OCS for patients attending A&E with asthma attacks? Yes! But first we have to consider barriers and facilitators to proving better long-term asthma management in Emergency Departments. It’s more than just updated guidelines.